The product does NOT contain any epitope tags. The protein has a calculated MW of 17.4 kDa. The protein migrates as 18 kDa on a SDS-PAGE gel under reducing (R) condition.
>95% as determined by reduced SDS-PAGE.
>95% as determined by SEC-MALS.
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.
Contact us for customized product form or formulation.
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
Biotinylated Human TNF-alpha, epitope tag free, primary amine labeling (active trimer) (MALS verified) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.
The purity of Biotinylated Human TNF-alpha, epitope tag free, primary amine labeling (active trimer) (MALS verified) (Cat. No. TNA-H8211) was more than 95% in HP-SEC, and the molecular weight of this protein is around 48-65 kDa verified by SEC-MALS.
Immobilized Humira at 5 μg/mL (100 μL/well) can bind Biotinylated Human TNF-alpha, epitope tag free, primary amine labeling (active trimer) (MALS verified) (Cat. No. TNA-H8211) with a linear range of 0.4-6 ng/mL (QC tested).
Authors: Gao R, et al
Journal: Opt Express 2020
Application: cross activity
Authors: M El Amrani, et al
Journal: Journal of Translational Autoimmunity 2019
Authors: D Lebert, et al
Journal: US20190011455A1 2019
Application: Affinity chromatography
Authors: Lebert Dorothée, et al
Journal: US20180321253A1 2018
Application: Mass Spectrometry ImmunoAffinity
Authors: Yu Bo, et al.
Journal: US20180313834A1 2018
Application: Flow Cytometry
Authors: P Sabhachandani, et al.
Journal: Microchim Acta 2015
Application: Microsphere-based assay
Authors: B Yu, et al.
Journal: US20140155285A1 2014
Application: Antibody Screening by FACS
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
ACROBiosystems has developed a series of critical reagents for COVID-19 vaccine development and evaluation,including proteins, antibodies and kits. These featured products are suitable for IgG/M antibody titer detection, neutralizing antibody titer detection and antigen titer detection.
High quality SARS-CoV-2 S protein, S1 protein and human ACE2 protein based on the human cell expression platform of HEK293.
ACROBiosystems has developed a serial of high-quality antigen and antibody reagents, including super stable trimeric S protein, S RBD, S1, S2, N proteins mainly expressed by HEK 293 and paired antibodies with outstanding sensitivity verified by inactivated virus samples.
ACROBiosystems has developed a series of kit products using its high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development.
This web search service is supported by Google Inc.